drugset / Trial / NCT00657917
Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
Phase 2
Terminated
1 enrolled
U.S. Army Medical Research and Development Command
Walter Reed Army Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this protocol is to treat laboratory confirmed cutaneous leishmaniasis with WR 279,396 in military health care beneficiaries. In this study "cutaneous leishmaniasis" is defined as Old World Leishmaniasis if acquired in the Southwest Central Asia/Middle East.
Timeline
- Start
- 2006-12-20
- Primary completion
- 2007-06-08
- Completion
- 2010-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gentamicin | Small molecule | — | Topical |
| Subject | Paromomycin | Small molecule | — | Topical |